CGTX Earnings

Quarterly EPS
$-0.25
Q3 2024
$-0.18
Q4 2024
$-0.14
Q1 2025
$-0.11
Q2 2025
$-0.06
Q3 2025
$-0.04
Q4 2025
$-0.05
Q1 2026
$-0.04
Q2 2026
Latest RevenueN/A
Latest Net Income-3932000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.040-3932000+63.6%
Q1 2026-$0.050-4570000+64.3%
Q4 2025-$0.040-3343000+77.8%
Q3 2025-$0.060-4930000+76.0%
Q2 2025-$0.110-6734000+38.9%
Q1 2025-$0.140-8480000+48.1%
Q4 2024-$0.180-7842000+30.8%
Q3 2024-$0.250-9937000-13.6%
Q2 2024-$0.180-7041000
Q1 2024-$0.270-9151000
Q4 2023-$0.260-8141000
Q3 2023-$0.220-6749000
Cognition Therapeutics (CGTX) — Earnings